Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Multiple sklerose
by Most Patent Filings in the Japan in 2022

The Multiple sklerose top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filings Multiple sklerose Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Clinical trial,
...[+2]
Patent: 23
2
Diagnostic Reagent,Medicine,Health care,
...[+2]
Patent: 23
3
Patent: 23
4
Medicine,Health care,Clinical trial,
...[+2]
Patent: 21
5
Patent: 21
6
Patent: 18
7
Fiber,Textile,Textile (markup language),
...[+2]
Patent: 14
8
Patent: 14
9
Patent: 13
10
Oncology,Medicine,Health care,
...[+2]
Patent: 11
11
Medicine,Health care,Toxoid,
...[+2]
Patent: 9
12
Diagnostic agent,Health care,Drug,
...[+2]
Patent: 8
13
Health care,Patiromer,Cardiovascular agent,
...[+2]
Patent: 8
14
Patent: 7
15
Patent: 7
16
Patent: 6
17
Patent: 6
18
Contract Manufacturing,Medicine,Chemical engineering,
...[+2]
Patent: 6
19
Drug,Clinical trial,Health care,
...[+2]
Patent: 5
20
Biosimilar,Health care,Ranibizumab,
...[+2]
Patent: 5
Page generation time: Jul 22 2025